Moderna co-founder Noubar Afeyan likens AI agents to living organisms and says sellers should have to prove them safe
Bloomberg Television · Video interview
Read the source (opens in a new tab)- What happened
- At a Bloomberg New Economy Forum panel in New Delhi, Moderna co-founder and chairman Noubar Afeyan said AI agents are "crossing a threshold" and urged people to "think carefully about regulating agents that are being commercialized."
- Key points
- Afeyan said agents that adapt and act without human direction start to resemble "a living organism that has adapting capability, swarming capability, ecosystem building capability."
- He said early 2026 warnings that agents would spread and form communities doing "unpredictable things" came true within six months, and that agents "can escape."
- Citing thalidomide, he argued that those who sell agents should have to show they are safe; agents built for one's own use "may be harder to regulate."
- He said unintended consequences such as new biomaterials also call for regulation: "Synthetic biology is another area which we really need to look at very carefully."
- Evidence
- Recording of a panel discussion; one founder's argument, not evidence of harm. The automatic captions have no speaker labels, so attribution rests on the moderator's cues.